top of page

The Lee Lab's Researches


Research field_The Lee Lab.png

At the forefront of biomedical research, the Lee Laboratory is dedicated to pioneering advancements in the realms of therapeutics, immunology, and biotechnology. Our multidisciplinary approach combines cutting-edge scientific inquiry with a deep commitment to improving human health.

Therapeutics: Pushing the Boundaries of Medicine

Our therapeutics research is at the vanguard of innovation, encompassing a broad spectrum of groundbreaking projects. We specialize in developing novel therapies through a diverse array of platforms:

  • Naked Antibody Drug: Harnessing the power of monoclonal antibodies to target and neutralize specific pathogens or cancer cells.

  • Bispecific or Multispecific Antibody: Crafting antibodies capable of engaging multiple targets, enhancing therapeutic efficacy.

  • Bio-PROTAC: Pioneering protein degradation technologies to selectively eliminate disease-causing proteins.

  • CAR-T, CAR-NK, CAR-M Therapies: Advancing cellular therapies with engineered T-cells, Natural Killer cells, and macrophages for targeted cancer treatment.

  • ADC (Antibody-Drug Conjugates): Combining antibodies with cytotoxic agents to deliver targeted treatments for cancer.


Immunology: Deciphering the Complexities of Immune Responses

Our immunology division delves into the intricate workings of the immune system, with a particular focus on:

  • Humoral Immunity Profiling: Investigating the body's antibody-mediated immune response to identify key protective mechanisms.

  • Fc Receptor Mediated Immunity: Exploring the critical role of Fc receptors in immune system activation and regulation.

  • Mechanism of Antibody Action: Unraveling the fundamental principles behind antibody functionality and action.

Biotechnology: Revolutionizing Antibody Discovery and Development

In our biotechnology sector, we are reshaping the landscape of antibody research through:

  • New Antibody Discovery Platform: Utilizing advanced techniques to uncover novel antibodies with therapeutic potential.

  • New Antibody Development Platform: Streamlining the process of antibody development, from discovery to clinical application.

Join us as we embark on this exciting journey, merging science, innovation, and dedication to revolutionize the field of biomedical research.

bottom of page